Polycystic Ovarian Syndrome Market Growth Analysis by Competitors, Industry Trends & Outlook 2022-2030

0
2KB

Polycystic Ovarian Syndrome Market Overview

The Polycystic Ovarian Syndrome Market Growth is expected to witness tremendous growth owing to the rising prevalence of polycystic ovarian syndrome. Other key factors such as the growing obesity among women, increase in hormonal disorders in women, change in sedentary lifestyle, socioeconomic factors, growing consumption of unhealthy diet, increasing occurrence of diabetes in women, and others are contributing towards the growth of the market. However, factors such as high cost of diagnostic procedures, expensive treatments, and side effects associated with drugs are expected to hinder the market growth during the forecast period.

Segmentation

The global polycystic ovarian syndromes market is segmented on the basis of diagnosis, treatment, and end-user. The polycystic ovarian syndrome medicine, by diagnosis, is categorized into pelvic examination, transvaginal ultrasound, and blood tests. Blood tests are further sub-segmented into hormone levels, glucose tolerance, and cholesterol and triglyceride levels. On the basis of treatment, the symptoms of polycystic ovarian syndrome is segmented into oral contraceptives, antiandrogens, insulin-sensitizing agents, antidepressant, anti-obesity, and surgery. The surgery category includes ovarian wedge resection and laparoscopic ovarian drilling. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and others.     

Regional Analysis

The Americas is expected to dominate the Polycystic Ovarian Syndrome Market Growth during the forecast period. The increasing prevalence of polycystic ovarian syndrome drives the market in this region. According to the Centers for Disease Control and Prevention, the Polycystic Ovary Syndrome (PCOS) affects 6 to 12% of the American women of the childbearing age. This is expected to influence the market growth during the forecast period.  

Europe (UK, Belgium, France, and Netherlands) is the second largest in the market owing to the increasing prevalence of obesity and growing healthcare expenditure. The increasing research activities for Polycystic Ovary Syndrome (PCOS) are influencing the market growth.   EuroSciCon will hold the 5th World Congress on Polycystic Ovarian Disorder in April 2019 in Berlin, Germany to discuss diagnosis and intervention of the polycystic ovarian syndrome.

Asia-Pacific was projected to be the fastest growing region for the global Polycystic Ovarian Syndrome Market Growth in 2017. The market is expected to witness growth owing to the rising prevalence of diabetes in women, changing lifestyle, and growing obesity within the female population. The Asian Diabetes Prevention Initiative estimated that by 2030 India and China will have a diabetic patient pool with a total of half billion people. Furthermore, according to the Journal of the American Medical Association in 2013, China had 187.7 million women suffering from prediabetes. This is expected to provide favorable backgrounds for the market to grow.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

Key Players

Some of the key players in the global Polycystic Ovarian Syndrome Market Growth are Bayer AG, AstraZeneca plc, Abbott, Biocinese, Catalysis, S.L., Crinetics Pharmaceuticals, Inc., Sanofi, Eugonia, EffRx, Inc., Ferring Pharmaceuticals, Inc., Merck KGaA, Bristol-Myer Squibb Company, Neurocrine Biosciences, Inc., Reliance Life Sciences Pvt. Ltd. Pfizer, Inc., Novartis AG, and Shire Plc.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/polycystic-ovarian-syndrome-market-6295

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

 

 

 

Rechercher
Commandité
Catégories
Lire la suite
Autre
Cold Pressed Juice Market is Anticipated to Witness High Growth Owing to Increasing Health Conscious Population
Cold pressed juice is a process in which ripe fruits and vegetables are slowly crushed and...
Par Naufan Muhammed 2024-06-19 09:13:26 0 598
Autre
Aluminum Shots Manufacturing Plant Project Report 2024: Raw Materials, Investment Opportunities, Cost and Revenue
IMARC Group’s report, titled “Aluminum Shots Manufacturing Plant Project Report 2024:...
Par jon Batiste 2024-05-24 07:18:46 0 657
Health
Fildena 120: Buy online| buyfirstmeds
What is Fildena 120Mg? Fildena 120 contains a comparative substance compound like other Fildena...
Par George Georged 2022-05-09 04:53:45 0 2KB
Autre
https://www.facebook.com/PureEaseCBDGummiesPainReliefSolution
Pure Ease CBD Gummies: What Are They?Pure Ease CBD Gummies are a wholesome supplement...
Par Shanne Watson 2023-10-09 09:24:39 0 993
Art
2022 Cert C-S4FCC-2021 Exam & C-S4FCC-2021 Reliable Exam Practice - Interactive SAP Certified Application Associate - SAP S/4HANA Finance for Group Reporting Associates (SAP S/4HANA 2021) Course
SAP C-S4FCC-2021 Cert Exam I am not sure if my payment was successful or not, With the help of...
Par Vwk5njfy Vwk5njfy 2022-12-12 01:35:13 0 2KB